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A model for predicting pancreatic leakage after 
pancreaticoduodenectomy based on the international 
study group of pancreatic surgery classification
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Yonsei University Health System, Seoul, Korea
Backgrounds/Aims: With recent advances in pancreatic surgery, pancreaticoduodenectomy (PD) has become increas-
ingly safe. However, pancreatic leakage is still one of the leading postoperative complications. An accurate prediction 
model for pancreatic leakage after PD can be helpful for pancreas surgeons. The aim of this study was to provide 
a new model that was simple and useful with high accuracy for predicting pancreatic leakage after PD. Methods: To 
predict the occurrence of pancreatic leakage, several factors were selected using bivariate analysis and univariate 
logistic regression analysis. The final model was developed using multivariable logistic regression analysis in the model 
construction data set. Results: Overall, 41 of 100 patients had pancreatic leakage by the International Study Group 
on Pancreatic Fistula (ISGPF) criteria. Soft pancreatic parenchyma, small pancreatic duct diameter (≤3 mm), and 
combined resection of SMV and portal vein were independently predictive of pancreatic leakage. The risk score (R) 
for individual patients can be calculated by combining the 3 prognostic values with the regression test: R= 
0.5986+(0.5533×pancreatic parenchyma)+(0.5448×pancreatic duct diameter)+(0.8453×combined resection). The overall 
predictive accuracy of the model, as measured by the receiver operating characteristic (ROC) curve, was 0.728 
Conclusions: Although continued refinements and improvements in the model are needed, the present model may 
assist pancreatic surgeons in the prediction of pancreatic leakage after PD. (Korean J Hepatobiliary Pancreat Surg 
2013;17:166-170)
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INTRODUCTION
With recent advances in pancreatic surgery, pan-
creaticoduodenectomy (PD) in high-volume centers has 
become increasingly safe.1-4 However, the morbidity rate 
remains high, with complication rates remaining around 
40%.1-4 In PD, pancreatic leakage is still one of the lead-
ing postoperative complications, often resulting in pro-
longed hospital stay and operative mortality. 
In previous reports, some factors predictive of pancre-
atic leakage after PD, such as old age, anastomotic techni-
ques, small pancreatic duct, and soft pancreatic texture, 
have been reported.5-10 However, no model has been de-
veloped to accurately predict pancreatic leakage after PD. 
An accurate prediction model for pancreatic leakage after 
PD can be helpful for pancreatic surgeons. Using the stat-
istical methods that have been successful in predicting ax-
illary node metastasis,11,12 we developed a method for pre-
dicting pancreatic leakage after PD. We chose the most 
objective definition of pancreatic leakage as defined by 
the International Study Group on Pancreatic Fistula 
(ISGPF).13
The aim of this study was to provide a new model that 
is simple and useful and has a high accuracy for predict-
ing pancreatic leakage after PD. 
METHODS
Patients
Between January 2003 and June 2008, 140 patients 
with benign or malignant periampullary pathology under-
went PDs at the Department of Surgery, Gangnam 
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Severance Hospital, Yonsei University Health System, 
Seoul, Korea. Eleven patients were excluded because of 
incomplete clinicopathologic data or loss to follow up. As 
a result, 129 patients who underwent PD were retro-
spectively reviewed. This study was approved by the 
Institutional Review Board of Yonsei University for retro-
spective chart review and data collection.
Operative procedure and perioperative 
management
In pylorus-preserving pancreaticoduodenectomy (PPPD), 
we removed the gallbladder, distal common bile duct, head 
of the pancreas, duodenum (except for the first portion), 
and 10-15 cm of the proximal jejunum. The proximal duo-
denum was carefully preserved 2-4 cm distal to the pylorus 
ring. The right gastric artery was divided along with the 
pyloric branch of the vagus nerve. Conventional PD was 
performed in the usual manner. All patients underwent dis-
section of the lymph nodes in the hepatoduodenal ligament, 
common hepatic artery, and celiac axis.
As a first step in reconstruction, the proximal jejunum 
was brought through the transverse mesocolon by the ret-
rocolic route. Pancreaticojejunostomy was performed with 
a duct-to-mucosa anastomosis in all patients. The inner 
layer was a duct-to-mucosa with interrupted 5-0 prolene 
sutures and a short internal stent. The outer layer was a 
seromuscular envelope with interrupted 4-0 vicryl Lembert 
sutures. No pancreaticogastrostomies were performed. 
Hepaticojejunostomy was performed as end-to-side with 
single-layer interrupted sutures at 15 cm proximal to the 
pancreatojejunostomy. Duodenojejunostomy (or gastro-
jejunostomy) was constructed using a two-layer anasto-
mosis by the antecolic route. A closed suction silicon drain 
(Jackson-Pratt, Baxter Health Care Corp.; Deerfield, IL) 
was placed in the patient from the right upper quadrant 
dorsal to the pancreatojejunal and the biliary anastomoses.
As a policy of our department, all patients received ant-
acid drugs for stress ulcer prophylaxis, and octreotide 
(SandostatinⓇ 150 μg) was subcutaneously administered 
postoperatively for 7 days.
Assessment of pancreatic consistency
In all cases, the pancreatic duct diameter was measured 
after pancreatic transection by the operator. Fibrotic 
changes were assessed by trichrome staining. After stain-
ing, the texture of the pancreatic parenchyma was divided 
into two groups based upon the thickness of the fibrotic 
changes in the resection margin at a lower magnification 
(×40 magnification). Soft pancreatic parenchyma was 
characterized by the absence of fibrosis, or by a slightly 
thick layer of perilobular fibrosis (≤50 μm). Hard paren-
chyma was characterized by a layer of thick perilobular 
fibrosis of ＞50 μm.
Classification of pancreatic fistula
A pancreatic fistula is defined by the output via an op-
erative drain of drain fluid of any measurable volume on 
or after postoperative day 3, with an amylase content 
greater than 3 times the upper normal serum level (＞300 
IU/L) according to the ISGPF definition.13 All patients be-
low this threshold were considered to have no fistula.
Study model construction
For model construction and validation, using 100 trials, 
the patients were randomly divided into 2 independent sets. 
The model set consisted of 100 patients. To predict occur-
rence of pancreatic leakage, several factors were selected 
using bivariate analysis and univariate logistic regression 
analysis; all measures of statistical significance were based 
on 0.05. The final model was developed using multi-
variable logistic regression analysis, and the calibration 
was assessed using the Akaika Information Criterion and 
c-statistics. Occurrence of pancreatic leakage was recorded 
as events and no leakage was recorded as non-events.
Study model validation 
An independent validation set was used to validate the 
statistical model to predict pancreatic leakage. They in-
cluded 19 men and 10 women, and their mean age was 
57.8±12.7 years (range 28-81 years). The prevalence rate 
of pancreatic leakage was 44.8% (n=13). Validation was 
performed with calculation of the area under the receiver 
operating characteristic curves (AUC) after applying 
nomograms of the new model. For accuracy of the vali-
dation set, the same random sample selection method was 
carried out 5 times and generated 5 different validation 
sets, regardless of the independence of the model set. After 
verification of the similarity of the 5 sets, the original vali-
dation set including all patients was finally used. All the 
analyses used the SAS system 9.1.3 (SAS Institute Inc, 
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Table 1. Comparisons of candidate risk factors between the pancreatic leakage (PL) group and non-PL group
Parameters PL group (n=41) Non-PL group (n=59) p-value
Age (mean, yrs)
Gender (n)
 Male
 Female
Operation name (n)
 Pancreatioduodencectomy (PD)
 Pylorus-preserving PD
Pathology origin (n)
 Pancreas 
 Ampulla of Vater/bile duct/duodeunal 
Pancreatic duct size (n)
 ≤3 mm 
 ＞3 mm
Pancreas texture (n)
 Soft 
 Hard 
SMV and portal vein resection (n)
 Yes 
 No
Intraoperative blood loss (ml)
Intra-operative transfusion (n)
 ≤2 units
 ＞2 units
Mean operation time (min)
63.8±9.7
25
16
14
27
5
36
22
19
15
26
10
31
1,540.2±100.1
24
17
492.6±100.1
59.3±12.3
32
27
17
42
28
31
19
40
9
50
4
55
998.5±547.7
45
14
428.3±90.0
0.054
0.543
0.571
0.0001
0.039
0.018
0.018
0.503
0.059
0.228
SMV, superior mesenteric vein
Cary, North Carolina) AUC, and 95% confidence intervals 
(CI) were calculated using MedCalc (demo version).
RESULTS
Patient characteristics for modeling 
A total of 100 patients who underwent PD or PPPD 
were selected for this study. The average age of patients 
was 61.1±11.5 years and consisted of 57 men and 43 
women. Of the 100 patients, 31 underwent PD and 69 un-
derwent PPPD. Pathologic diagnosis was pancreatic carci-
noma in 31 patients, chronic pancreatitis in 2 patients, bile 
duct cancer in 38, ampulla of Vater cancer in 24, ampulla 
of Vater adenoma in 2 patients and duodenal carcinoma 
in 3. There were no the overall in-hospital mortality.
Pancreatic leakage
The average pancreatic duct diameter was 3.6±2.1 mm, 
41 patients had normal pancreatic ducts (≤3 mm), and 
59 had dilated pancreatic ducts (>3 mm). There were 24 
patients (24%) with soft pancreatic texture and 76 patients 
(76%) with hard pancreatic texture.
Overall, 41 of 100 patients had pancreatic leakage by 
the ISGPF criteria13 for an overall incidence of 41%. 22 
patients were grade A (22.0%), 18 were grade B (18.0%) 
and 2 were grade C (2.0%). 
Pre- and intraoperative risk factors for pancreatic leak-
age were compared between patients with and without 
pancreatic leakage. The incidence of pancreatic leakage 
was significantly higher in the group with soft pancreatic 
parenchyma, small pancreatic duct diameter (≤3 mm), 
combined resection of the SMV and portal vein, and can-
cer of non pancreatic origin (bile duct, ampulla of Vater, 
duodenal) (Table 1). The candidate predictor variables 
were assessed using each univariate logistic analysis. In 
the multivariate analysis, soft pancreatic parenchyma, 
small pancreatic duct diameter (≤3 mm), pathology of 
non-pancreatic origin and combined resection of the SMV 
and portal vein were identified as independent factors for 
pancreatic leakage after PD (Table 2). 
Predicting model construction
Soft pancreatic parenchyma increased the risk of pan-
creatic leakage by 3.02 times, small pancreatic duct diam-
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Table 2. Multivariate analysis of risk factors for pancreatic leakage 
Parameters Odds ratio 95% confidence interval p-value
Soft pancreatic parenchyma 
Small pancreatic duct (≤3 mm)
Combined resection of SMV and portal vein
Pathology of origin (Non-pancreas)
2.21
3.25
11.39 
10.33
0.75-6.48
1.23-8.60
2.24-58.03
2.66-40.11
0.033
0.017
0.002
0.001
SMV, superior mesenteric vein
Fig. 1. ROC curve for the risk score predicting pancreatic 
leakage in validation.
eter (≤3 mm) by 2.97 times, and combined resection of 
the SMV and portal vein by 5.42 times.
The risk score (R) for individual patients can be calcu-
lated by combining the 3 prognostic values with the re-
gression test: R=0.5986+(0.5533×pancreatic parenchyma) 
+(0.5448×pancreatic duct diameter)+(0.8453×combined re-
section). The pancreatic parenchyma was coded as 0 for 
hard and 1 for soft. The pancreatic duct diameter was clas-
sified as 0 for large (＞3 mm) and 1 for small (≤3 mm). 
Combined resection was coded as 0 for non resection of 
the SMV/portal vein and 1 for combined resection of the 
SMV and portal vein.
For example, for a hypothetical patient with a pancre-
atic duct diameter of 2 mm with soft pancreatic paren-
chyma and who did not have resection of the SMV, the 
risk score would be as follows: R=0.5986+(0.5533×1)+ 
(0.5448×1)+(0.8453×0)=1.6967.
The overall predictive accuracy of the model as meas-
ured by the ROC curve was 0.728 (95% CI: 0.630 to 
0.812).
Study model validation
To validate the model, we plotted the probabilities pre-
dicted by the observed proportions in 29 patients who un-
derwent PD. C-statistics can be regarded as an extension 
of the AUC. The AUC for prediction of pancreatic leak-
age by the model was 0.714 (95% CI 0.517 to 0.865) 
(Fig. 1).
DISCUSSION
After PD, pancreatic leakage may occur in 5%-30% of 
patients. This wide range of occurrence in different stud-
ies could be partially explained by differences in the defi-
nition of pancreatic leakage.10,14-19 The variance obviously 
precludes accurate comparisons of surgical techniques and 
outcomes. To overcome this problem, the International 
Study Group of Pancreatic Surgery on Pancreatic fistula 
(ISGPF) suggested a universal and applicable definition of 
pancreatic leakage in 2005.13 The ISGPF definition of 
pancreatic leakage is very strict and objective criteria, 
which is why we chose it for this study.
Pancreatic leakage is a leading postoperative complica-
tion of PD, often resulting in prolonged hospital stay and 
operative mortality. Thus, it is important to be able to pre-
dict which patients are more likely to develop pancreatic 
leakage after PD. In previous reports, some factors pre-
dictive of pancreatic leakage after PD, including old age, 
anastomotic techniques, small pancreatic duct, and soft 
pancreatic texture, have been reported.5-10 We have shown 
that pancreatic duct size, texture of the remnant pancreatic 
parenchyma, and combined resection of the SMV were 
significantly associated with the risk of pancreatic leakage 
in the multivariate analysis. Although these predictive fac-
tors have been recognized, we think that they may not be 
independently but interdependently related to pancreatic 
leakage after PD.
In this study, we developed methods for predicting pan-
creatic leakage after PD. The model is a calculator pro-
gram using pancreatic duct size, texture of the remnant 
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pancreatic parenchyma, and concomitant surgery. The 
c-static for prediction of pancreatic leakage by our model 
was 0.728 (95% CI 0.630-0.812). The model was also va-
lidated in an independent set of patients and the c-static 
for prediction of pancreatic leakage was 0.714 (95% CI 
0.517-0.865). Generally, an AUC＞0.7 is considered a 
useful test result; we think that our model is an objective 
method for predicting pancreatic leakage after PD. Our 
model utilizes readily available clinical information and 
allows quick calculations to be made. It is a predictive 
instrument that can accurately identify high-risk patients 
for pancreatic leakage and could be used as a tool in the 
decision-making process.
There are some limitations of our model. First, it does 
no present varying degrees of clinical severity. In fact, 
grade A leakage is not significant because it may be clin-
ically silent. Therefore, this model alone cannot predict 
the true clinical impact on patients. Second, our model is 
imperfect. It included sample sizes of less than 200 pa-
tients and had decreased predictive accuracy when applied 
to subjects. This failure may be due to the limited sample 
size. Large-scale evaluation of patients would provide a 
revised value of the parameter estimator. Finally, a poten-
tial weakness of our data is that all patients underwent 
the same pancreatic anastomosis technique performed by 
a single surgeon. Therefore, other pancreaticojejunostomy 
anastomosis techniques, such as pancreaticogastrostomy, 
dunking anastomosis, and pancreaticojejunal invagination 
were not included in our model. However, there is still 
no clear evidence for or against any type of anastomosis.
Nonetheless, the advantage of this model is that it is 
based on multivariable analysis, and is objective and the 
variables of pancreatic duct diameter, texture of pancreatic 
parenchyma, and combined resection of the SMV and por-
tal vein are easily available. Before the model can be wide-
ly accepted, it will need to be validated by other inves-
tigators in independent groups of patients undergoing PD.
Although continued refinement and improvement of the 
model is needed, the present model may be useful for 
pancreatic surgeons in the prediction of pancreatic leakage 
after PD. We hope that other institutions will use our 
model using their databases, which will likely contain dif-
ferent patient characteristics, to validate its accuracy and 
to refine its ability. 
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